Tilray CEO: Opportunities in medical cannabis are huge
Tilray’s stock is up this present day, nonetheless serene down 80 percent from a February excessive. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon about the…
Tilray’s stock is up this present day, nonetheless serene down 80 percent from a February excessive. CNBC’s Frank Holland reports on his conversation with Tilray CEO Irwin Simon about the…